National Cancer Centre Singapore and Lucence Diagnostics Announce First Molecular Test that Selects Immunotherapy for Kidney Cancer. - Study was conducted on 36 kidney cancer patients using the CLEARScore test that identifies eight genes linked to immunotherapy. - Findings from this study will be presented at the 2019 ASCO Genitourinary Cancers Symposium in San Francisco.
